An Implantable Immunosuppressive Cyclosporine Drug Delivery System


Article Preview

In the article a kind biodegradable drug carrier (glycolide-co-lactide-co-caprolactone) tricomponent copolymer (PGLC) was synthesized by ring opening copolymerization of glycolide (GA), lactide (LA) and ε-caprolactone (CL), and was used to manufacture an implantable drug preparation---Cyclosporine-PGLC drug delivery system (Cs-PGLC DDS).The Cs could slowly release from the Cs-PGLC DDS near linearly and last for a long time in vitro. A clinically significant Cs concentration in the cornea and anterior chamber could be achieved by implanting the Cs-PGLC DDS in anterior chamber. It was demonstrated that the Cs-PGLC DDS is a long-effective intraocular immunosuppressive agent for remaining corneal allograft clear and significantly prolong its survival time.



Key Engineering Materials (Volumes 288-289)

Edited by:

Xingdong Zhang, Junzo Tanaka, Yaoting Yu and Yasuhiko Tabata




S. G. Wang et al., "An Implantable Immunosuppressive Cyclosporine Drug Delivery System", Key Engineering Materials, Vols. 288-289, pp. 125-128, 2005

Online since:

June 2005




[1] M.W. Belin, C.S. Bouchard, S. Frantz, et al. Ophthalmology 1989, 96: 1144-50.

[2] C.B. Carpenter, N Engl J Med 1990, 322: 1224-6.

[3] L.X. Xie, W.Y. Shi, S.G. Wang, et al. Cornea, 2001, 20(7): 748-752.

[4] S.G. Wang, 《Bio-medical Materials》 Chief Editor: Y.T. Yu, Tianjin University Press (2000), p.182.

[5] Q. Cai, J.Z. Bei, S.G. Wang, J Biomat Sci. Polym Ed 2000, 3: 273-88.

[6] S.G. Wang, L.X. Xie, J.Z. Bei, et al. Chinese Patent 00122863. 3.

Fetching data from Crossref.
This may take some time to load.